QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis
Business Wire•13/10/2026•16:05 ET
0
Key Highlights
- ➤10.7 million people developed tuberculosis worldwide in 2024
- ➤Nearly 1.2 million people died from tuberculosis in 2024
- ➤Global health funding cuts threaten TB prevention, diagnostic and treatment services
- ➤QIAGEN will convene global TB experts October 13-16
- ➤More than 160 million QuantiFERON-TB tests sold worldwide since launch
Expert Statements
Christine Ginocchio, Chief Medical Officer at QIAGEN
“The world has made progress against tuberculosis, but that progress cannot be taken for granted.”
Christine Ginocchio, Chief Medical Officer at QIAGEN
“Millions of people still develop TB every year, and pressure on funding and public health systems could slow further advances.”
Christine Ginocchio, Chief Medical Officer at QIAGEN
“Bringing experts together, strengthening education and identifying people with TB infection are practical ways we can help sustain momentum toward better prevention and care.”
QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis
* Global TB Summit brings together international experts as persistent disease burden and funding pressures challenge progress against tuberculosis
Get started
Create a free account to read the full story.